Abstract Details
|
Debra J. Ehrlich, MD, FÂé¶¹´«Ã½Ó³»
(NIH/NINDS)
PRESENTER |
Dr. Ehrlich has nothing to disclose. |
| Jorge D. Correale, MD (Institute for Neurological Research) | Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Correale has received research support from Merck. The institution of Dr. Correale has received research support from Biogen. The institution of Dr. Correale has received research support from Novartis . |
| Atul K. Ramesh, MD (INOVA) | No disclosure on file |
| Steven Herskovitz, MD, FÂé¶¹´«Ã½Ó³» (Dept of Neuro/ EMG Montefiore Med Ctr) | No disclosure on file |
| Howard L. Geyer, MD, PhD (Montefiore Medical Center) | Dr. Geyer has received publishing royalties from a publication relating to health care. |
| No disclosure on file | |
| Karen M. Weidenheim, MD | No disclosure on file |
| Jerome J. Graber, MD, MPH, FÂé¶¹´«Ã½Ó³» (University of Washington) | Dr. Graber has received personal compensation for serving as an employee of Binaytara Foundation. Dr. Graber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Âé¶¹´«Ã½Ó³». Dr. Graber has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dickie McCamey Attorneys at Law. Dr. Graber has a non-compensated relationship as a Editorial Board member with Neuro-Oncology: Practice, published by Oxford that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. Dr. Graber has a non-compensated relationship as a Editorial Board Member with Journal of Pain and Symptom Management that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. Dr. Graber has a non-compensated relationship as a Board of Directors with American Society of Neuroimaging that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. Dr. Graber has a non-compensated relationship as a Board of Directors and Certification Exam Committee Member with United Council of Neurological Subspecialties that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. Dr. Graber has a non-compensated relationship as a Question of the Day 'app' committee and NeuroSAE and Continuum with Âé¶¹´«Ã½Ó³» that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. Dr. Graber has a non-compensated relationship as a Editorial Board Member with Practical Neurology (BMC) that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. |